Could an allergy pill ease Parkinson's? new trial launches

NCT ID NCT06785298

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether fexofenadine, a common allergy medication, can improve quality of life for people with Parkinson's disease who are already on standard treatment. Researchers will enroll 46 adults aged 50 and older with mild to moderate Parkinson's. The main goal is to see if adding fexofenadine helps reduce symptoms like slowness, stiffness, and tremor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tanta University

    RECRUITING

    Tanta, 31511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.